Vaccines human papilloma virus

Pallecaros A, Vonau B. Human papilloma virus vaccine - more than a vaccine. Curr Opin Obstet Gynecol 2007 19(6) 541-6. 

Human Papilloma Virus Vaccine [SED-15, 1698 SEDA-33, 657 SEDA-34, 501 SEDA-35, 574] General... 

Human milk, citric acid in, 6 632t Human papilloma virus (HPV) vaccine, 25 497... 

Our laboratory uses a mouse model to study preventative and therapeutic vaccination strategies for human papilloma virus (HPV)-associated tumors. For preventative vaccination studies, six- to eight-week-old female C57BL/6 mice are injected subcutaneously with LPDI on days 0 and 5 and are challenged on day 10 with a subcutaneous injection of 10 E7-expressing TC-1 tumor cells with tumor growth measured three times weekly. 

Gardasil is a quadrivalent vaccine of the human papilloma virus (type 6, 11, 16, 18). It is used for the prevention of cervical cancer and other pre-cancerous lesions. It should be given early in a female s sexual life and it is licensed for use in females between 9 and 26 years of age. Administration is by intramuscular injection and three doses are required. Because the vaccine does not protect against all the strains of the virus, cervical screening is still required. Duration of protection after a complete course is... 

Recombinant DNA processes can be used to make subunit vaccines. These can be classified either as biological or fermentation processes. Hepatitis B vaccines are made by genetic manipulation of yeast or animal cells. The cells then express the hepatitis B virus outer coat protein, which is harmless to the host because there is no DNA present. Similarly, in 2007, two companies launched a vaccine for cervival cancer caused by the human papilloma virus (HPV). 

In the field of prophylactic vaccination, a variety of vaccines has reached the market place during the past few decades. However, many attempts to prevent infectious diseases such as AIDS, malaria and tuberculosis - as well as infections caused by hepatitis G virus (HGV), human papilloma virus (HPV), herpes simplex vims or GMV - have failed. The reasons for this failure are the devious methods used by pathogens to outflank the immune system. 

Clough ). Edible vaccines against human papilloma virus. Drug Discov. Today, 2002 7(17) 886-887. 

Conjugated Hib vaccine (Hib capsular antigen polyribosylphosphate covalently linked to the non-toxic diphtheria toxin variant CRM197) HBV Hepatitis B virus Hib Haemophilus influenzae type b HPV Human papilloma virus... 

Example human papilloma virus quadrivalent vaccine In 2007 in Sweden, the manufacturer was asked to provide every 6 months additional data on ongoing and planned studies in order to determinate the cost-effectiveness from a long-term perspective. 

---